Vyome【HIND】銘柄情報

Vyome Holdings Inc (HIND) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

2.14

( 1.42% )

買値

1.66

売値

2.74

出来高

18,107

2.13 日の範囲 2.21

1.75 52 週間の範囲 12.87

時価総額

15.02M

前日終値

2.11

始値

2.13

時刻

2.15

最終取引時間

財務取引量

US$ 39,411

VWAP

2.1765

平均取引量 (3 か月)

US$ 26,968

発行済株式数

7,018,528

配当利回り

PER

-0.76

1 株当たり利益 (EPS)

-2.85

歳入

152.72k

純利益

-10.93M

Vyome Holdings, Inc., a clinical-stage specialty pharmaceutical company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States. It operates through Pharmaceutical and Biotechnology segments. The company’s lead product candidate VT-1953, a dual DNA Gyrase/... Vyome Holdings, Inc., a clinical-stage specialty pharmaceutical company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States. It operates through Pharmaceutical and Biotechnology segments. The company’s lead product candidate VT-1953, a dual DNA Gyrase/Topoisomerase inhibitor and immunomodulator in a topical gel formulation that is in phase 2 clinical stage for the treatment of bacterial conjunctivitis. It also develops VT-1908, a topical eye drop is an inosine 5'-monophosphate dehydrogenase enzyme inhibitor to treat immunoinflammatory conditions of the eye; and VB-1953, which is in phase 2 clinical stage for the treatment of inflammatory acne. In addition, the company develops antifungal products using the molecular replacement therapy (MRT) platform. It has a collaboration and license agreement with Sun Pharma Laboratories Limited to develop and commercialize next-generation antifungal products. The company is based in Cambridge, Massachusetts. 詳細を表示

セクター

Healthcare

業界

Medical Equipment & Supplies

ウェブサイト

www.vyometx.com

本社

Cambridge, United States

設立

Vyome Holdings Inc is listed in the Healthcare sector of the ナスダック市場 with ticker HIND. The last closing price for Vyome was US$2.11. Over the last year, Vyome shares have traded in a share price range of US$ 1.75 to US$ 12.87.

Vyome currently has 7,018,528 shares in issue. The market capitalisation of Vyome is US$15.02 million. Vyome has a price to earnings ratio (PE ratio) of -0.76.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.08	-3.6036036036	2.22	2.35	2.1	26618	2.11973834	CS
4	-0.18	-7.75862068966	2.32	2.4314	2.1	23038	2.20245221	CS
12	0	0	2.14	2.5	1.81	27810	2.12808306	CS
26	-1.53	-41.689373297	3.67	3.84	1.75	436603	3.10748314	CS
52	-10.71	-83.3463035019	12.85	12.87	1.75	350818	4.00779368	CS
156	-10.71	-83.3463035019	12.85	12.87	1.75	350818	4.00779368	CS
260	-10.71	-83.3463035019	12.85	12.87	1.75	350818	4.00779368	CS